Review Your Insurance Policy Start by reviewing your plans drug formulary
Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health
Zhao R, Matherly LH, Goldman ID
Vimentin treatment increased transcription of GLUT1 and hypoxia-inducible factor 1 (Hif-1) but decreased GLUT4 transcription
Proc Natl Acad Sci 100:1467214677 Singla-Pareek SL, Yadav SK, Pareek A, Reddy MK, Sopory SK (2006) Transgenic tobacco overexpressing glyoxalase pathway enzymes grow and set viable seeds in zinc-spiked soils
Treatment options include surgery, chemotherapy, targeted therapy, immunotherapy, and sometimes radiation therapy
